ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,529.89
      1.05%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Galectin Therapeutics Inc (GALT)

      7. Galectin Therapeutics Inc (GALT) News

      GALT

      Galectin Therapeutics (GALT)

      Galectin Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GALT
      DateTimeSourceHeadlineSymbolCompany
      01/30/20195:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/23/20196:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/23/20194:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/18/20195:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      01/15/20198:00AMGlobeNewswire Inc.Galectin Therapeutics’ Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Strea...NASDAQ:GALTGalectin Therapeutics Inc
      01/15/20197:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      01/03/20198:32AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GALTGalectin Therapeutics Inc
      12/20/20188:30AMGlobeNewswire Inc.Galectin Therapeutics Announces Extension of $10 Million Line CreditNASDAQ:GALTGalectin Therapeutics Inc
      12/20/20188:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      11/19/20189:19AMGlobeNewswire Inc.Galectin Therapeutics to Present at the 2nd Annual Anti-Fibrotic Drug Development SummitNASDAQ:GALTGalectin Therapeutics Inc
      11/13/20188:00AMGlobeNewswire Inc.Galectin Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      11/13/20187:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      11/13/20187:54AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GALTGalectin Therapeutics Inc
      11/05/20188:00AMGlobeNewswire Inc.Data Collected by Exalenz Bioscience in Galectin Therapeutics’ Phase 2 NASH-CX Trial of GR-MD-02 to Be Presented at AASLD A...NASDAQ:GALTGalectin Therapeutics Inc
      10/15/201810:22AMGlobeNewswire Inc.Galectin Therapeutics to Participate in The ROTH Capital Battle of the NASH Thrones Investment ConferenceNASDAQ:GALTGalectin Therapeutics Inc
      10/15/20188:00AMGlobeNewswire Inc.Galectin Therapeutics to Present at The ROTH Capital Battle of the NASH Thrones Investment ConferenceNASDAQ:GALTGalectin Therapeutics Inc
      09/28/20184:36PMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:GALTGalectin Therapeutics Inc
      09/28/20184:34PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:GALTGalectin Therapeutics Inc
      09/26/20188:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      09/25/201812:31PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GALTGalectin Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GALT